Beckman Coulter, Inc.

Christophe P Godefroy

Patricio Vidal

John Riley

Jiuliu Lu

Phaisit Chewputtanagul

Carlos Ramirez

Mark A Wells

Jose M Cano

Andreas Van Agthoven

Fabrice Malergue

Carlos A Perez

Valentin T Quesada

Eileen Landrum

Jindan Zhou

Enrique Rabellino

Maritza Lavernia

Jorge Leon

Gregory Yeager

John Steven Riley

Patricio J Vidal

Embodiments of the present invention encompass systems and methods for detecting the presence of a test pad on a test strip. Exemplary techniques involve receiving a test strip having at least one test pad, where individual test pads have a pad width with ink disposed on two ink zones at two opposing sides of the width of the pad, illuminating the at least one test pad with a light source, detecting reflected signals from the test pad, generating an image comprising of pixels of the two ink zones based on the reflected signals, detecting the presence of each of the ink zones by comparing the number of consecutive pixels against a predetermined threshold, and determining the presence of the test pad on the test strip if two ink zones are detected within the pad width.

Sheared pad detection systems and methods

Systems and methods are provided for determining the age of cellular hemoglobin in individual red blood cells in a blood sample by determining the percentage of HbA1c. In embodiments, a method includes measuring side scatter and fluorescence of the individual red blood cells and identifying immature red blood cells and mature red blood cells from the side scatter and fluorescence measurement. In embodiments, data collected includes the exact number of red blood cells, the fraction limits in fluorescence and side scatter units, the mean value of each fraction in fluorescence and side scatter units, the mean FL1 values per fraction in arbitrary units and the mean side scatter values per fraction in arbitrary units. In embodiments, a method also includes deriving a HbA1c content from the measured mean fluorescence of the individual red blood cells and determining the percentage of HbA1c from the HbA1c content and the hemoglobin content of the red blood cells.

Systems and methods to determine the age of cells

Embodiments of the present invention encompass automated systems and methods for analyzing immature platelet parameters in an individual based on a biological sample obtained from blood of the individual. Exemplary techniques involve correlating aspects of direct current (DC) impedance, radiofrequency (RF) conductivity, and/or light measurement data obtained from the biological sample with an evaluation of immature platelet conditions in the individual.

Immature platelet enumeration systems and methods

Embodiments of the present invention encompass automated systems and methods for analyzing white blood cell parameters in an individual based on a biological sample obtained from blood of the individual. Exemplary techniques involve correlating aspects of direct current (DC) impedance, radiofrequency (RF) conductivity, and/or light measurement data obtained from the biological sample with an evaluation of white blood cell conditions in the individual.

Method and apparatus for determining white blood cell counts

Methods, systems, and computer program products for the analysis of a blood sample are disclosed. One embodiment is a method of detecting and enumerating hard-to-ghost cells in a blood sample. Another embodiments is a method of analyzing reticulocytes in a blood sample. Methods of using blood count parameters are also provided.

Method and system for analyzing a blood sample

Methods, systems, and computer program products for the analysis of particle analyzer data are disclosed. One embodiment is a method of analyzing immature reticulocytes in a blood sample, including the steps of: preprocessing the blood sample; measuring the blood sample by a detection including a reticulocyte-maturity measurement and a light scatter measurement; analyzing blood cell distribution patterns to identify a set of reticulocyte events; differentiating immature reticulocytes from mature reticulocytes using the reticulocyte-maturity measurement and the light scatter measurement; and reporting immature reticulocytes. The immature reticulocyte fraction may be one aspect that is reported. Also another method is disclosed, having the steps of: measuring the blood sample by a detection comprising an axial light loss measurement; identifying a hard-to-ghost cell population based on the axial light loss measurement; filtering-out the hard-to-ghost cell population; and analyzing the event data to identify blood cell distribution patterns.

Analyzing reticulocytes

In an embodiment, a computer-implemented method is provided for processing data from a particle analyzer. The method includes transforming data using at least one transform that provides: transformation according to a weighted combination of a first mathematical function and a logarithmic function for positive data values, such that the transformation corresponds to the first mathematical function for positive particle data values approaching zero, and to the logarithmic function for positive particle data values approaching infinity; and transformation corresponding to a second mathematical function for negative data values. The transformed data may be then output for display or storage. In another embodiment, the transforming involves substituting the particle data for an independent variable in the transform to directly obtain values to be plotted based on the input particle data values.

Methods and systems for transforming particle data

The present invention relates to a hematology instrument system that discriminates platelets from red blood cells, debris and other particles within a blood sample. The instrument system uses an optical trigger and collects data at optical sensor locations relative to a flow cell-illuminating laser beam's optical axis. An axial sensor measures axial light loss due to a particle in the flow cell's illumination aperture. In addition, the instrument system can include an RF unit generates electrical parameters, such as DC and RF parameters, within the flow cell. Blood specimens can be prepared with and without a sphering agent.

Growing community of inventors

Miami, FL, United States of America

Christophe P Godefroy